On Monday, B.Riley initiated coverage on ULTA Beauty (NASDAQ: ULTA) with a Sell rating and a price target of $300 per share. The firm highlighted ULTA's significant growth in the beauty specialty retail sector over the last decade, acknowledging the company's strong revenue growth. Despite this, the firm sees potential earnings risks that may outweigh the benefits of ULTA's currently low valuation.
ULTA Beauty, recognized for its impressive top-line compound annual growth rate (CAGR) of over 15%, has been a major beneficiary of the beauty industry's expansion. However, B.Riley points out that even with the stock's decline of more than 20% year-to-date (YTD), there are concerns about future earnings amid possible industry slowdowns and increasing competition.
The coverage notes that while ULTA's valuation is lower compared to historical ranges, this does not mitigate the concerns regarding persistent same-store sales declines. B.Riley forecasts that these declines may continue through the end of the year and possibly into 2025.
The firm also warns of potential margin pressures due to a rise in promotional activity and the challenge of fixed cost de-leverage. These factors could contribute to a less favorable financial performance for ULTA Beauty in the near future.
B.Riley's initiation of coverage with a Sell rating indicates a cautious stance on ULTA Beauty's stock, suggesting that investors should be aware of the risks associated with the company's earnings and market position. The price target of $300 reflects the firm's assessment of these challenges facing ULTA Beauty.
In other recent news, ULTA Beauty has experienced several adjustments to its stock price targets following its second-quarter earnings report. Loop Capital reduced the stock price target from $520 to $450, while maintaining a Buy rating, despite the company's weaker-than-expected financial results.
Similarly, DA Davidson lowered its price target from $507.00 to $435.00, Citi reduced its target from $375 to $345, and Oppenheimer adjusted its target to $435 from $450. TD Cowen also reduced its target from $500 to $395. Despite these reductions, all firms maintained positive ratings on the company's stock.
ULTA Beauty reported modest Q2 net sales growth of 0.9% to $2.6 billion, but also experienced a 1.2% decline in comparable store sales. The company's earnings per share (EPS) of $5.30 did not meet the anticipated Street forecast of $5.47, reflecting weaker sales and profit margins than predicted. Consequently, ULTA's management revised its full-year EPS guidance for fiscal year 2024 to a range of $22.60 to $23.50, which falls short of the Street's expectation of $25.25. Despite the challenges, ULTA Beauty demonstrated resilience by opening 17 new stores during the quarter.
InvestingPro Insights
As ULTA Beauty navigates the challenges highlighted by B.Riley, real-time data from InvestingPro offers additional context for investors considering the stock. ULTA's management has been proactively buying back shares, a sign of confidence in the company's value (InvestingPro Tip). Additionally, while 24 analysts have revised their earnings downwards for the upcoming period, ULTA's liquid assets surpass short-term obligations, indicating a sound liquidity position (InvestingPro Tip).
InvestingPro Data shows ULTA with a market capitalization of $17.93 billion and a P/E ratio of 15.21, reflecting a valuation that is lower than its historical average. The company's price to book ratio stands at 7.66, which may suggest a premium compared to the industry standard. Despite recent price volatility, with a 6-month total return of -31.96%, ULTA has experienced a strong recovery over the last month, with a total return of 14.1%. This rebound may interest investors looking for a potentially undervalued stock in the beauty sector.
For those seeking further guidance, InvestingPro offers additional tips on ULTA Beauty's financial health and market performance. Visit InvestingPro for more insights, including an expansive list of tips to help refine your investment strategy.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.